Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 271 AL 285

Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation

Corbett A, Sultana J, Stych K, Mills R, Cummings JL, Williams G, Ismail Z, Soto-Martin M, Mintzer J, Gauthier S, Greig NH, Noble W, Killick R, Lai MKP, Routledge C, Walsh F, Fillit H, Aarsland D, Lane R, Mills K, Ballard C.

Alzheimers Res Ther. 2025 Nov 18;17(1):237. doi: 10.1186/s13195-025-01895-4.

The Gut-Brain Axis in Alzheimer's Disease: Exploring Microbial Influences and Therapeutic Strategies

Mustafa MA, Vadia N, Varma P, Al-Shaker H, Mohanty B, Dhyani A, Kaur I, Chauhan AS, Garg G.

Mol Neurobiol. 2025 Nov 24;63(1):151. doi: 10.1007/s12035-025-05474-4.

The calpain-mediated proteolytic cleavage peptide P10 modulates Tau phosphorylation in Alzheimer's disease

Chinnathambi S, Dubey T, Rangappa N.

Adv Protein Chem Struct Biol. 2025;148:481-505. doi: 10.1016/bs.apcsb.2025.08.009. Epub 2025 Aug 30.

Precision therapeutics for Alzheimer's disease

Priyanka S, Manjari T, Hemalatha S, Ambika S, Yılmaz B, Aktürk B, Arısan ED, Kumari A, Manojkumar Y.

Prog Brain Res. 2025;297:247-276. doi: 10.1016/bs.pbr.2025.08.011. Epub 2025 Sep 11.

Alzheimer's Disease: The Current and Emerging Treatment Approaches

Pang R, Jia Q, Ma C, Li T, Bi W, Wang H, Liu R, Chen P, Lee ES, Jiang HB.

Behav Neurol. 2025 Dec 7;2025:9627699. doi: 10.1155/bn/9627699. eCollection 2025.

Engineering exosomes for Alzheimer's disease: Multi-target therapeutic strategies from pathogenesis to clinical translation

Zhang Y, Li Z, Guan H, Qiu Z, Zou C.

Clin Transl Med. 2025 Dec;15(12):e70548. doi: 10.1002/ctm2.70548.

Role of tRNA-Derived Fragments and Their Modifications in the Pathogenesis and Treatment of Alzheimer's Disease

Li L, Kong J, Fan R, Yuan Y, Zhu L.

Mol Neurobiol. 2025 Dec 22;63(1):321. doi: 10.1007/s12035-025-05603-z.

APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer's Disease and Cardiovascular Disease

Liu C, Liu J, Wang YY, Xu SF, Yu LM.

Mol Neurobiol. 2025 Dec 23;63(1):325. doi: 10.1007/s12035-025-05629-3.

The evolving landscape of Alzheimer's disease therapy: From Aβ to tau

Courade JP, Zetterberg H, Höglinger GU, Dewachter I.

Cell. 2025 Dec 24;188(26):7337-7354. doi: 10.1016/j.cell.2025.11.033.

Deep cervical lymphaticovenous anastomosis for Alzheimer's disease: A narrative review

Chen Q, Wen Q, Zhong T, Liu J, Gao H.

Alzheimers Dement. 2025 Dec;21(12):e71038. doi: 10.1002/alz.71038.

Active Immunization Targeting Amyloid β for the Treatment of Alzheimer's Disease

Triplett O, Varda N, Decourt B, Vasconcellos R, Sabbagh MN.

Neurodegener Dis. 2025;25(4):202-217. doi: 10.1159/000546287. Epub 2025 May 10.

Dendrimers: Patents for Alzheimer's Disease

Maheshwari S, Singh A.

Recent Pat Nanotechnol. 2025;19(3):356-363. doi: 10.2174/1872210517666230831154408.

Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review

Park JJ, Rim YA, Sohn Y, Nam Y, Ju JH.

Histol Histopathol. 2025 Feb;40(2):157-170. doi: 10.14670/HH-18-766. Epub 2024 May 21.

Advanced nano delivery system for stem cell therapy for Alzheimer's disease

Pan Y, Li L, Cao N, Liao J, Chen H, Zhang M.

Biomaterials. 2025 Mar;314:122852. doi: 10.1016/j.biomaterials.2024.122852. Epub 2024 Sep 30.

Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions

Almutary AG, Begum MY, Kyada AK, Gupta S, Jyothi SR, Chaudhary K, Sharma S, Sinha A, Abomughaid MM, Imran M, Lakhanpal S, Babalghith AO, Abu-Seer EA, Avinash D, Alzahrani HA, Alhindi AA, Iqbal D, Kumar S, Jha NK, Alghamdi S.

Ageing Res Rev. 2025 Feb;104:102548. doi: 10.1016/j.arr.2024.102548. Epub 2024 Oct 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias